Home Pharmaceuticals Multiple Sclerosis Drugs Market Size, Top Share, Forecast to 2033

Multiple Sclerosis Drugs Market Size & Outlook, 2025-2033

Multiple Sclerosis Drugs Market Size, Share & Trends Analysis Report By Drug Class (Immunomodulators, Immunosuppressants, Interferons, Others), By Route of Administration (Oral, Injectables, Infusions), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Stores), By Disease Type (Relapsing-remitting MS (RRMS), Primary-progressive MS (PPMS), Secondary-progressive MS (SPMS), Progressive-relapsing MS (PRMS)) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRPH1498DR
Last Updated : May, 2025
Pages : 110
Author : Mitiksha Koul
Format : PDF, Excel

Market Segmentation

  1. Multiple Sclerosis Drugs Market, By Drug Class (2021-2033)
    1. Immunomodulators
    2. Immunosuppressants
    3. Interferons
    4. Others
  2. Multiple Sclerosis Drugs Market, By Route of Administration (2021-2033)
    1. Oral
    2. Injectables
      1. Intramuscular
      2. Subcutaneous
      3. Intravenous
    3. Infusions
  3. Multiple Sclerosis Drugs Market, By Distribution Channel (2021-2033)
    1. Hospital Pharmacy
    2. Retail Pharmacy
    3. Online Stores
  4. Multiple Sclerosis Drugs Market, By Disease Type (2021-2033)
    1. Relapsing-remitting MS (RRMS)
    2. Primary-progressive MS (PPMS)
    3. Secondary-progressive MS (SPMS)
    4. Progressive-relapsing MS (PRMS)
    1. North America
      1. North America Multiple Sclerosis Drugs Market, By Drug Class
        1. Immunomodulators
          1. Immunosuppressants
            1. Interferons
              1. Others
              2. North America Multiple Sclerosis Drugs Market, By Route of Administration
                1. Oral
                  1. Injectables
                    1. Intramuscular
                      1. Subcutaneous
                        1. Intravenous
                        2. Infusions
                        3. North America Multiple Sclerosis Drugs Market, By Distribution Channel
                          1. Hospital Pharmacy
                            1. Retail Pharmacy
                              1. Online Stores
                              2. North America Multiple Sclerosis Drugs Market, By Disease Type
                                1. Relapsing-remitting MS (RRMS)
                                  1. Primary-progressive MS (PPMS)
                                    1. Secondary-progressive MS (SPMS)
                                      1. Progressive-relapsing MS (PRMS)
                                      2. U.S.
                                        1. U.S. Multiple Sclerosis Drugs Market, By Drug Class
                                          1. Immunomodulators
                                            1. Immunosuppressants
                                              1. Interferons
                                                1. Others
                                                2. U.S. Multiple Sclerosis Drugs Market, By Route of Administration
                                                  1. Oral
                                                    1. Injectables
                                                      1. Intramuscular
                                                        1. Subcutaneous
                                                          1. Intravenous
                                                          2. Infusions
                                                          3. U.S. Multiple Sclerosis Drugs Market, By Distribution Channel
                                                            1. Hospital Pharmacy
                                                              1. Retail Pharmacy
                                                                1. Online Stores
                                                                2. U.S. Multiple Sclerosis Drugs Market, By Disease Type
                                                                  1. Relapsing-remitting MS (RRMS)
                                                                    1. Primary-progressive MS (PPMS)
                                                                      1. Secondary-progressive MS (SPMS)
                                                                        1. Progressive-relapsing MS (PRMS)
                                                                      2. Canada
                                                                    2. Europe
                                                                      1. Europe Multiple Sclerosis Drugs Market, By Drug Class
                                                                        1. Immunomodulators
                                                                          1. Immunosuppressants
                                                                            1. Interferons
                                                                              1. Others
                                                                              2. Europe Multiple Sclerosis Drugs Market, By Route of Administration
                                                                                1. Oral
                                                                                  1. Injectables
                                                                                    1. Intramuscular
                                                                                      1. Subcutaneous
                                                                                        1. Intravenous
                                                                                        2. Infusions
                                                                                        3. Europe Multiple Sclerosis Drugs Market, By Distribution Channel
                                                                                          1. Hospital Pharmacy
                                                                                            1. Retail Pharmacy
                                                                                              1. Online Stores
                                                                                              2. Europe Multiple Sclerosis Drugs Market, By Disease Type
                                                                                                1. Relapsing-remitting MS (RRMS)
                                                                                                  1. Primary-progressive MS (PPMS)
                                                                                                    1. Secondary-progressive MS (SPMS)
                                                                                                      1. Progressive-relapsing MS (PRMS)
                                                                                                      2. U.K.
                                                                                                        1. U.K. Multiple Sclerosis Drugs Market, By Drug Class
                                                                                                          1. Immunomodulators
                                                                                                            1. Immunosuppressants
                                                                                                              1. Interferons
                                                                                                                1. Others
                                                                                                                2. U.K. Multiple Sclerosis Drugs Market, By Route of Administration
                                                                                                                  1. Oral
                                                                                                                    1. Injectables
                                                                                                                      1. Intramuscular
                                                                                                                        1. Subcutaneous
                                                                                                                          1. Intravenous
                                                                                                                          2. Infusions
                                                                                                                          3. U.K. Multiple Sclerosis Drugs Market, By Distribution Channel
                                                                                                                            1. Hospital Pharmacy
                                                                                                                              1. Retail Pharmacy
                                                                                                                                1. Online Stores
                                                                                                                                2. U.K. Multiple Sclerosis Drugs Market, By Disease Type
                                                                                                                                  1. Relapsing-remitting MS (RRMS)
                                                                                                                                    1. Primary-progressive MS (PPMS)
                                                                                                                                      1. Secondary-progressive MS (SPMS)
                                                                                                                                        1. Progressive-relapsing MS (PRMS)
                                                                                                                                      2. Germany
                                                                                                                                      3. France
                                                                                                                                      4. Spain
                                                                                                                                      5. Italy
                                                                                                                                      6. Russia
                                                                                                                                      7. Nordic
                                                                                                                                      8. Benelux
                                                                                                                                      9. Rest of Europe
                                                                                                                                    2. APAC
                                                                                                                                      1. APAC Multiple Sclerosis Drugs Market, By Drug Class
                                                                                                                                        1. Immunomodulators
                                                                                                                                          1. Immunosuppressants
                                                                                                                                            1. Interferons
                                                                                                                                              1. Others
                                                                                                                                              2. APAC Multiple Sclerosis Drugs Market, By Route of Administration
                                                                                                                                                1. Oral
                                                                                                                                                  1. Injectables
                                                                                                                                                    1. Intramuscular
                                                                                                                                                      1. Subcutaneous
                                                                                                                                                        1. Intravenous
                                                                                                                                                        2. Infusions
                                                                                                                                                        3. APAC Multiple Sclerosis Drugs Market, By Distribution Channel
                                                                                                                                                          1. Hospital Pharmacy
                                                                                                                                                            1. Retail Pharmacy
                                                                                                                                                              1. Online Stores
                                                                                                                                                              2. APAC Multiple Sclerosis Drugs Market, By Disease Type
                                                                                                                                                                1. Relapsing-remitting MS (RRMS)
                                                                                                                                                                  1. Primary-progressive MS (PPMS)
                                                                                                                                                                    1. Secondary-progressive MS (SPMS)
                                                                                                                                                                      1. Progressive-relapsing MS (PRMS)
                                                                                                                                                                      2. China
                                                                                                                                                                        1. China Multiple Sclerosis Drugs Market, By Drug Class
                                                                                                                                                                          1. Immunomodulators
                                                                                                                                                                            1. Immunosuppressants
                                                                                                                                                                              1. Interferons
                                                                                                                                                                                1. Others
                                                                                                                                                                                2. China Multiple Sclerosis Drugs Market, By Route of Administration
                                                                                                                                                                                  1. Oral
                                                                                                                                                                                    1. Injectables
                                                                                                                                                                                      1. Intramuscular
                                                                                                                                                                                        1. Subcutaneous
                                                                                                                                                                                          1. Intravenous
                                                                                                                                                                                          2. Infusions
                                                                                                                                                                                          3. China Multiple Sclerosis Drugs Market, By Distribution Channel
                                                                                                                                                                                            1. Hospital Pharmacy
                                                                                                                                                                                              1. Retail Pharmacy
                                                                                                                                                                                                1. Online Stores
                                                                                                                                                                                                2. China Multiple Sclerosis Drugs Market, By Disease Type
                                                                                                                                                                                                  1. Relapsing-remitting MS (RRMS)
                                                                                                                                                                                                    1. Primary-progressive MS (PPMS)
                                                                                                                                                                                                      1. Secondary-progressive MS (SPMS)
                                                                                                                                                                                                        1. Progressive-relapsing MS (PRMS)
                                                                                                                                                                                                      2. Korea
                                                                                                                                                                                                      3. Japan
                                                                                                                                                                                                      4. India
                                                                                                                                                                                                      5. Australia
                                                                                                                                                                                                      6. Taiwan
                                                                                                                                                                                                      7. South East Asia
                                                                                                                                                                                                      8. Rest of Asia-Pacific
                                                                                                                                                                                                    2. Middle East and Africa
                                                                                                                                                                                                      1. Middle East and Africa Multiple Sclerosis Drugs Market, By Drug Class
                                                                                                                                                                                                        1. Immunomodulators
                                                                                                                                                                                                          1. Immunosuppressants
                                                                                                                                                                                                            1. Interferons
                                                                                                                                                                                                              1. Others
                                                                                                                                                                                                              2. Middle East and Africa Multiple Sclerosis Drugs Market, By Route of Administration
                                                                                                                                                                                                                1. Oral
                                                                                                                                                                                                                  1. Injectables
                                                                                                                                                                                                                    1. Intramuscular
                                                                                                                                                                                                                      1. Subcutaneous
                                                                                                                                                                                                                        1. Intravenous
                                                                                                                                                                                                                        2. Infusions
                                                                                                                                                                                                                        3. Middle East and Africa Multiple Sclerosis Drugs Market, By Distribution Channel
                                                                                                                                                                                                                          1. Hospital Pharmacy
                                                                                                                                                                                                                            1. Retail Pharmacy
                                                                                                                                                                                                                              1. Online Stores
                                                                                                                                                                                                                              2. Middle East and Africa Multiple Sclerosis Drugs Market, By Disease Type
                                                                                                                                                                                                                                1. Relapsing-remitting MS (RRMS)
                                                                                                                                                                                                                                  1. Primary-progressive MS (PPMS)
                                                                                                                                                                                                                                    1. Secondary-progressive MS (SPMS)
                                                                                                                                                                                                                                      1. Progressive-relapsing MS (PRMS)
                                                                                                                                                                                                                                      2. UAE
                                                                                                                                                                                                                                        1. UAE Multiple Sclerosis Drugs Market, By Drug Class
                                                                                                                                                                                                                                          1. Immunomodulators
                                                                                                                                                                                                                                            1. Immunosuppressants
                                                                                                                                                                                                                                              1. Interferons
                                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                                                2. UAE Multiple Sclerosis Drugs Market, By Route of Administration
                                                                                                                                                                                                                                                  1. Oral
                                                                                                                                                                                                                                                    1. Injectables
                                                                                                                                                                                                                                                      1. Intramuscular
                                                                                                                                                                                                                                                        1. Subcutaneous
                                                                                                                                                                                                                                                          1. Intravenous
                                                                                                                                                                                                                                                          2. Infusions
                                                                                                                                                                                                                                                          3. UAE Multiple Sclerosis Drugs Market, By Distribution Channel
                                                                                                                                                                                                                                                            1. Hospital Pharmacy
                                                                                                                                                                                                                                                              1. Retail Pharmacy
                                                                                                                                                                                                                                                                1. Online Stores
                                                                                                                                                                                                                                                                2. UAE Multiple Sclerosis Drugs Market, By Disease Type
                                                                                                                                                                                                                                                                  1. Relapsing-remitting MS (RRMS)
                                                                                                                                                                                                                                                                    1. Primary-progressive MS (PPMS)
                                                                                                                                                                                                                                                                      1. Secondary-progressive MS (SPMS)
                                                                                                                                                                                                                                                                        1. Progressive-relapsing MS (PRMS)
                                                                                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                                                                                      1. LATAM Multiple Sclerosis Drugs Market, By Drug Class
                                                                                                                                                                                                                                                                        1. Immunomodulators
                                                                                                                                                                                                                                                                          1. Immunosuppressants
                                                                                                                                                                                                                                                                            1. Interferons
                                                                                                                                                                                                                                                                              1. Others
                                                                                                                                                                                                                                                                              2. LATAM Multiple Sclerosis Drugs Market, By Route of Administration
                                                                                                                                                                                                                                                                                1. Oral
                                                                                                                                                                                                                                                                                  1. Injectables
                                                                                                                                                                                                                                                                                    1. Intramuscular
                                                                                                                                                                                                                                                                                      1. Subcutaneous
                                                                                                                                                                                                                                                                                        1. Intravenous
                                                                                                                                                                                                                                                                                        2. Infusions
                                                                                                                                                                                                                                                                                        3. LATAM Multiple Sclerosis Drugs Market, By Distribution Channel
                                                                                                                                                                                                                                                                                          1. Hospital Pharmacy
                                                                                                                                                                                                                                                                                            1. Retail Pharmacy
                                                                                                                                                                                                                                                                                              1. Online Stores
                                                                                                                                                                                                                                                                                              2. LATAM Multiple Sclerosis Drugs Market, By Disease Type
                                                                                                                                                                                                                                                                                                1. Relapsing-remitting MS (RRMS)
                                                                                                                                                                                                                                                                                                  1. Primary-progressive MS (PPMS)
                                                                                                                                                                                                                                                                                                    1. Secondary-progressive MS (SPMS)
                                                                                                                                                                                                                                                                                                      1. Progressive-relapsing MS (PRMS)
                                                                                                                                                                                                                                                                                                      2. Brazil
                                                                                                                                                                                                                                                                                                        1. Brazil Multiple Sclerosis Drugs Market, By Drug Class
                                                                                                                                                                                                                                                                                                          1. Immunomodulators
                                                                                                                                                                                                                                                                                                            1. Immunosuppressants
                                                                                                                                                                                                                                                                                                              1. Interferons
                                                                                                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                                                                                                                2. Brazil Multiple Sclerosis Drugs Market, By Route of Administration
                                                                                                                                                                                                                                                                                                                  1. Oral
                                                                                                                                                                                                                                                                                                                    1. Injectables
                                                                                                                                                                                                                                                                                                                      1. Intramuscular
                                                                                                                                                                                                                                                                                                                        1. Subcutaneous
                                                                                                                                                                                                                                                                                                                          1. Intravenous
                                                                                                                                                                                                                                                                                                                          2. Infusions
                                                                                                                                                                                                                                                                                                                          3. Brazil Multiple Sclerosis Drugs Market, By Distribution Channel
                                                                                                                                                                                                                                                                                                                            1. Hospital Pharmacy
                                                                                                                                                                                                                                                                                                                              1. Retail Pharmacy
                                                                                                                                                                                                                                                                                                                                1. Online Stores
                                                                                                                                                                                                                                                                                                                                2. Brazil Multiple Sclerosis Drugs Market, By Disease Type
                                                                                                                                                                                                                                                                                                                                  1. Relapsing-remitting MS (RRMS)
                                                                                                                                                                                                                                                                                                                                    1. Primary-progressive MS (PPMS)
                                                                                                                                                                                                                                                                                                                                      1. Secondary-progressive MS (SPMS)
                                                                                                                                                                                                                                                                                                                                        1. Progressive-relapsing MS (PRMS)
                                                                                                                                                                                                                                                                                                                                      2. Mexico
                                                                                                                                                                                                                                                                                                                                      3. Argentina
                                                                                                                                                                                                                                                                                                                                      4. Chile
                                                                                                                                                                                                                                                                                                                                      5. Colombia
                                                                                                                                                                                                                                                                                                                                      6. Rest of LATAM

                                                                                                                                                                                                                                                                                                                                  Available for purchase with detailed segment data, forecasts, and regional insights.

                                                                                                                                                                                                                                                                                                                                  Get This Report

                                                                                                                                                                                                                                                                                                                                  Download Free Sample

                                                                                                                                                                                                                                                                                                                                  Note: Please ensure you provide an active email address as we will be sending sample details via email.
                                                                                                                                                                                                                                                                                                                                  The button will be active once the above form is filled

                                                                                                                                                                                                                                                                                                                                  Our Clients:

                                                                                                                                                                                                                                                                                                                                  LG Electronics
                                                                                                                                                                                                                                                                                                                                  AMCAD Engineering
                                                                                                                                                                                                                                                                                                                                  KOBE STEEL LTD.
                                                                                                                                                                                                                                                                                                                                  Hindustan National Glass & Industries Limited
                                                                                                                                                                                                                                                                                                                                  Voith Group
                                                                                                                                                                                                                                                                                                                                  International Paper
                                                                                                                                                                                                                                                                                                                                  Hansol Paper
                                                                                                                                                                                                                                                                                                                                  Whirlpool Corporation
                                                                                                                                                                                                                                                                                                                                  Sony
                                                                                                                                                                                                                                                                                                                                  Samsung Electronics
                                                                                                                                                                                                                                                                                                                                  Qualcomm
                                                                                                                                                                                                                                                                                                                                  Google
                                                                                                                                                                                                                                                                                                                                  Fiserv
                                                                                                                                                                                                                                                                                                                                  Veto-Pharma
                                                                                                                                                                                                                                                                                                                                  Nippon Becton Dickinson
                                                                                                                                                                                                                                                                                                                                  Merck
                                                                                                                                                                                                                                                                                                                                  Argon Medical Devices
                                                                                                                                                                                                                                                                                                                                  Abbott
                                                                                                                                                                                                                                                                                                                                  Ajinomoto
                                                                                                                                                                                                                                                                                                                                  Denon
                                                                                                                                                                                                                                                                                                                                  Doosan
                                                                                                                                                                                                                                                                                                                                  Meiji Seika Kaisha Ltd
                                                                                                                                                                                                                                                                                                                                  LG Chemicals
                                                                                                                                                                                                                                                                                                                                  LCY chemical group
                                                                                                                                                                                                                                                                                                                                  Bayer
                                                                                                                                                                                                                                                                                                                                  Airrane
                                                                                                                                                                                                                                                                                                                                  BASF
                                                                                                                                                                                                                                                                                                                                  Toyota Industries
                                                                                                                                                                                                                                                                                                                                  Nissan Motors
                                                                                                                                                                                                                                                                                                                                  Neenah
                                                                                                                                                                                                                                                                                                                                  Mitsubishi
                                                                                                                                                                                                                                                                                                                                  Hyundai Motor Company

                                                                                                                                                                                                                                                                                                                                  We are featured on :

                                                                                                                                                                                                                                                                                                                                  Address:
                                                                                                                                                                                                                                                                                                                                  Office 515 A, Amanora Chambers,
                                                                                                                                                                                                                                                                                                                                  Amanora Park Town, Hadapsar,
                                                                                                                                                                                                                                                                                                                                  Pune 411028, Maharashtra, India.
                                                                                                                                                                                                                                                                                                                                  Contact Us:
                                                                                                                                                                                                                                                                                                                                  +1 646 905 0080 (U.S.)
                                                                                                                                                                                                                                                                                                                                  +91 8087085354 (India)
                                                                                                                                                                                                                                                                                                                                  +44 203 695 0070 (U.K.)

                                                                                                                                                                                                                                                                                                                                  sales@straitsresearch.com

                                                                                                                                                                                                                                                                                                                                  Quick Links
                                                                                                                                                                                                                                                                                                                                  Help
                                                                                                                                                                                                                                                                                                                                  Verified. Protected. Secure.
                                                                                                                                                                                                                                                                                                                                  DMCA.com Protection Status
                                                                                                                                                                                                                                                                                                                                  Secure Payments:
                                                                                                                                                                                                                                                                                                                                  Follow Us:
                                                                                                                                                                                                                                                                                                                                  www.straitsresearch.com © Copyright . All rights Reserved.